Quantcast

Latest aortic aneurysm Stories

2011-08-08 08:00:00

IRVINE, Calif., Aug. 8, 2011 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today that the first U.S. commercial implant of the Company's AFX(TM) Endovascular AAA System was performed at Edward Hines, Jr. VA Hospital in Chicago, IL. The procedure was performed by Ross Milner, M.D., F.A.C.S., Associate Professor and Chief of Vascular Surgery & Endovascular Therapy at Loyola University in Chicago,...

2011-08-03 15:15:00

IRVINE, Calif., Aug. 3, 2011 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at two upcoming investor conferences. The first presentation will be at the 31st Annual Canaccord Genuity Growth Conference in Boston, MA. Event: 31st Annual Canaccord Genuity Growth Conference Date: Thursday, August...

2011-07-26 21:08:30

Stent makes 'coiling' surgery more promising option The addition of a simple stent can help prevent potentially lethal blood vessel bulges in the brain from recurring after they are repaired in a minimally invasive "coiling" procedure, according to new research by Johns Hopkins physicians. A report on the research, published in the July Journal of Neurointerventional Surgery, could make coiling a more viable option for the 30,000 people diagnosed with brain aneurysms each year in the United...

2011-07-25 13:19:00

SANTA ROSA, Calif., July 25, 2011 /PRNewswire/ -- TriVascular, Inc. today announced the successful treatment of the first 5 patients in the OVATION study, a multicenter, prospective, European Post Market Registry. The patients were treated in Germany at Stadtisches Klinikum, Karlsruhe by Prof. Martin Storck and at Universitares Herz und Gefasszentrum, Hamburg by Dr. Hans Krankenberg. "It is an honor to be the first site to enroll a patient in TriVascular's OVATION study. Ovation's...

2011-07-18 07:30:00

IRVINE, Calif., and BURLINGTON, Mass., July 18, 2011 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer and marketer of minimally invasive treatments for aortic disorders, and LeMaitre Vascular, Inc. (Nasdaq: LMAT), provider of peripheral vascular devices and implants, announced today that the companies have entered into an early termination agreement for LeMaitre's distribution rights of Endologix's aortic endovascular products in Europe. Under the terms of the agreement,...

2011-07-12 08:00:00

IRVINE, Calif., July 12, 2011 /PRNewswire/ -- Endologix, Inc. (NASDAQ: ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its second quarter 2011 financial results, which will take place on Thursday, July 21, 2011 after the close of the market. Endologix will hold a conference call on Thursday, July 21, 2011 at 5:00 p.m. ET / 2:00 p.m. PT to discuss the results. The dial-in numbers are (877) 407-0789 for...

2011-06-17 13:20:01

Results published today in PLoS Genetics Patients with thoracic aortic aneurysms that lead to acute aortic dissections are 12 times more likely to have duplications in the DNA in a region of chromosome 16 (16p13.1) than those without the disease, according to a study led by genetic researchers at The University of Texas Health Science Center at Houston (UTHealth). The results of the innovative study, which included researchers at Baylor College of Medicine, are published in the June 16 issue...

2011-06-17 13:09:38

People who have duplications in a region of chromosome 16 (16p13.1) that is present in approximately 1 in 1000 individuals have a 12-fold increased risk of thoracic aortic aneurysms leading to a tear in the aorta, or acute aortic dissections. An estimated 10000 people die annually from thoracic aortic aneurysms and dissections (TAAD) in the United States, where TAAD have ranked as high as the 15th leading cause of death. The study, led by genetic researchers at The University of Texas Health...

2011-06-15 08:00:00

IRVINE, Calif., June 15, 2011 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its next generation product, the AFX(TM) Endovascular AAA System, for the treatment of abdominal aortic aneurysms (AAA). Endologix is introducing AFX at the Annual Meeting of the Society for Vascular Surgery (SVS), which is taking place June...

2011-06-15 00:00:28

Wisconsin Governor Scott Walker files resolution marking September as Brain Aneurysm Awareness Month in the state of Wisconsin at the recommendation of Brenda Schmittinger, a local survivor. Hanover, MA (PRWEB) June 13, 2011 On April 15, 2011 the Wisconsin State Legislature passed a resolution declaring September 2011 to be Brain Aneurysm Awareness Month. The resolution is designed to raise awareness of the dangers of brain aneurysms and increase public awareness of the symptoms and...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related